专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20050090433A1 Dalbavancin compositions for treatment of bacterial infections 审中-公开
公开(公告)号：US20050090433A1
公开(公告)日：2005-04-28
申请号：US10493558
申请日：2003-11-14
申请人： Luigi Colombo , Adriano Malabarba , Martin Stogniew
发明人： Luigi Colombo , Adriano Malabarba , Martin Stogniew
IPC分类号： A61K31/70 , A61K31/704 , A61K38/12 , A61K38/14 , A61P31/04
CPC分类号： A61K38/14 , A61K31/70 , A61K31/704 , A61K38/00 , A61K2300/00
摘要： The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Compositions comprise a mixture of dalbavancin multimer and monomer and a stabilizer, such as dextrose.

22. 发明授权

US07655676B2 Use of amide derivative of GE 2270 factor A3 for the treatment of acne 有权
标题翻译：使用GE 2270因子A3的酰胺衍生物治疗痤疮
公开(公告)号：US07655676B2
公开(公告)日：2010-02-02
申请号：US10518802
申请日：2003-06-06
申请人： Adriano Malabarba , Marco Cavaleri , Giorgio Mosconi , Daniela Jabes , Gabriela Romano
发明人： Adriano Malabarba , Marco Cavaleri , Giorgio Mosconi , Daniela Jabes , Gabriela Romano
IPC分类号： A61K31/44 , A01N43/78 , C07D277/60 , C07D417/00 , C07D513/00
CPC分类号： A61K38/12
摘要： Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl, Y represents the group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity against propionibacterium acne and are suitable for use in a method of treatment or prevention of acne.
摘要翻译：式（I）化合物及其药学上可接受的加成盐在制备用于局部治疗的药物或5防止痤疮配方（I）中的用途，其中：R表示甲氧基甲基，R1表示甲基，Rz表示甲基，Y表示基团式（II）式（I）化合物及其药学上可接受的酸加成盐显示对丙酸杆菌的选择性活性，适用于治疗或预防痤疮的方法。

23. 发明申请

US20050130909A1 Dalbavancin compositions for treatment of bacterial infections 审中-公开
标题翻译：达巴万星组合物治疗细菌感染
公开(公告)号：US20050130909A1
公开(公告)日：2005-06-16
申请号：US10714166
申请日：2003-11-14
申请人： Luigi Colombo , Adriano Malabarba , Martin Stogniew
发明人： Luigi Colombo , Adriano Malabarba , Martin Stogniew
IPC分类号： A61K31/70 , A61K31/704 , A61K38/12 , A61K38/14 , A61P31/04
CPC分类号： A61K38/14 , A61K31/70 , A61K31/704 , A61K38/00 , A61K2300/00
摘要： The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Compositions comprise a mixture of dalbavancin multimer and monomer and a stabilizer, such as dextrose.
摘要翻译：本发明提供了用于治疗细菌感染的方法和组合物。本发明的方法包括施用达巴万星多聚体和用于治疗细菌感染的单体的混合物，特别是皮肤和软组织的革兰氏阳性细菌感染。组合物包括达巴万星多聚体和单体以及稳定剂如葡萄糖的混合物。

24. 发明申请

US20050032721A1 Methods of administering dalbavancin for treatment of skin and soft tissue infections 审中-公开
标题翻译：给予达巴万星治疗皮肤和软组织感染的方法
公开(公告)号：US20050032721A1
公开(公告)日：2005-02-10
申请号：US10942197
申请日：2004-09-15
申请人： Marco Cavaleri , Daniela Jabes , Timothy Henkel , Adriano Malabarba , Giorgio Mosconi , Martin Stogniew , Richard White
发明人： Marco Cavaleri , Daniela Jabes , Timothy Henkel , Adriano Malabarba , Giorgio Mosconi , Martin Stogniew , Richard White
IPC分类号： A61K31/70 , A61K31/704 , A61K38/12 , A61K38/14 , A61P31/04
CPC分类号： A61K38/14 , A61K31/70 , A61K31/704 , A61K38/00 , A61K2300/00
摘要： The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular an uncomplicated Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
摘要翻译：本发明提供了用于治疗细菌感染的方法和组合物。本发明的方法包括给予达巴万星治疗细菌感染，特别是皮肤和软组织的不复杂革兰氏阳性细菌感染。给药方案包括每周一次给予达巴万星，达巴万星通常在血液中保持治疗水平至少一周，为细菌感染提供长时间的治疗作用。

25. 发明授权

US5684127A Tetrapeptides deriving from dalbaheptide antibiotics 失效
公开(公告)号：US5684127A
公开(公告)日：1997-11-04
申请号：US468732
申请日：1995-06-06
申请人： Adriano Malabarba , Romeo Ciabatti
发明人： Adriano Malabarba , Romeo Ciabatti
IPC分类号： A61K38/00 , C07K5/107 , C07K9/00 , C07K1/02 , A61K38/07 , C07K5/10 , C07K5/12
CPC分类号： C07K9/008 , C07K5/1016 , A61K38/00 , Y02P20/55
摘要： Tetrapeptides of general formula (I) deriving from dalbaheptide antibiotics ##STR1## wherein: W and Z represent the relative portions of the aglycon of an antibiotic of the dalbaheptide group (aglucodalbaheptides); Y represents a carboxylic group or a functional derivative of said carboxylic group; R and R.sub.0 each independently represent amino or a protected amino group; R.sub.1 represents hydrogen or a protecting group of the carboxylic function; and its salts with acids and bases as well as its inner salts. A process for producing the tetrapeptides of formula (I) from the corresponding dalbaheptides and aglucodalbaheptides.

26. 发明授权

US5648456A Pentapeptide antibiotics 失效
标题翻译：五肽抗生素
公开(公告)号：US5648456A
公开(公告)日：1997-07-15
申请号：US454807
申请日：1995-05-31
申请人： Adriano Malabarba , Romeo Ciabatti , Jurgen Kurt Kettenring
发明人： Adriano Malabarba , Romeo Ciabatti , Jurgen Kurt Kettenring
IPC分类号： A61K38/00 , A61P31/04 , C07K1/02 , C07K1/107 , C07K7/06 , C07K7/64 , C07K9/00 , C07K14/195 , C07K14/41 , C07K5/00 , C07K7/00 , C07K16/00 , C07K17/00
CPC分类号： C07K9/008 , A61K38/00
摘要： Pentapeptide antibiotics of the formula ##STR1## wherein W, Z, X.sub.1, X.sub.2 and T represent the relative portions of an antibiotic of the dalbaheptide group (glyccpeptide antibiotics), Y represents a carboxyacid group, a functional derivative of said carboxyacid group or a hydroxymethyl group. The invention includes the salts of the above represented pentapeptide antibiotics with acids or bases as well as their inner salts.The compounds are obtained by reductive cleavage of the peptidic bond between the second and the third aminoacid of the seven aminoacid chain of dalbaheptides (glycopeptide antibiotics). The inventions concerns also the reductive cleavage process which implies using an alkali metal borohydride as the reagent. The compounds show antibacterial activity against staphylococcal and streptococcal strains.
摘要翻译：其中W，Z，X 1，X 2和T代表达巴庚肽组（glyccpeptide抗生素）的抗生素的相对部分，Y代表羧酸基团，所述羧酸基团的官能衍生物或羟甲基组。本发明包括上述五肽抗生素与酸或碱的盐以及它们的内盐。化合物通过还原性切割达巴庚啶（glycopeptide antibiotics）的七个氨基酸链的第二和第三个氨基酸之间的肽键来获得。本发明还涉及使用碱金属硼氢化物作为试剂的还原性裂解方法。该化合物对葡萄球菌和链球菌菌株具有抗菌活性。

27. 发明授权

US5644025A Tetrapeptides deriving from dalbaheptide antibiotics 失效
标题翻译：来自达贝己定抗生素的四肽
公开(公告)号：US5644025A
公开(公告)日：1997-07-01
申请号：US391378
申请日：1995-02-17
申请人： Adriano Malabarba , Romeo Ciabatti
发明人： Adriano Malabarba , Romeo Ciabatti
IPC分类号： A61K38/00 , C07K5/107 , C07K9/00 , C07K5/12 , C07K7/64
CPC分类号： C07K9/008 , C07K5/1016 , A61K38/00 , Y02P20/55
摘要： Tetrapeptides of general formula (I) deriving from dalbaheptide antibiotics ##STR1## wherein: W and Z represent the relative portions of the aglycon of an antibiotic of the dalbaheptide group (aglucodalbaheptides);Y represents a carboxylic group or a functional derivative of said carboxylic group;R and R.sub.0 each independently represent amino or a protected amino group;R.sub.1 represents hydrogen or a protecting group of the carboxylic function;and its salts with acids and bases as well as its inner salts.A process for producing the tetrapeptides of formula (I) from the corresponding dalbaheptides and aglucodalbaheptides.
摘要翻译：（I）衍生自达拉庚啶抗生素的通式（I）的四肽其中：W和Z代表达贝己定组（aglucodalbaheptides）的抗生素的糖苷配基的相对部分; Y表示所述羧基的羧基或官能衍生物; R和R 0各自独立地表示氨基或被保护的氨基; R1表示氢或羧基官能团的保护基; 及其与酸和碱的盐以及其内盐。从相应的达巴庚啶和氨基甜菜苷生产式（I）的四肽的方法。

28. 发明授权

US5521155A Amides of teicoplanin compounds 失效
标题翻译：替考拉宁化合物酰胺
公开(公告)号：US5521155A
公开(公告)日：1996-05-28
申请号：US389425
申请日：1995-02-14
申请人： Adriano Malabarba , Giorgio Tarzia
发明人： Adriano Malabarba , Giorgio Tarzia
IPC分类号： C07K7/64 , A61K31/33 , A61K35/74 , A61K38/00 , A61P31/04 , C07D519/00 , C07K1/06 , C07K1/113 , C07K9/00 , A61K38/12 , A61K38/14 , C07K7/54
CPC分类号： C07K9/008
摘要： The present invention is directed to an amide derivative of the glycopeptide, teicoplanin. This compound is an antibiotic that is active against gram positive bacteria. This compound is produced by subjecting teicoplanin to an amidation reaction.
摘要翻译：本发明涉及糖肽，替考拉宁的酰胺衍生物。该化合物是对革兰氏阳性菌有活性的抗生素。该化合物通过将替考拉宁进行酰胺化反应而制备。

29. 发明授权

US5869449A 38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibiotics and a process for preparing them 失效
标题翻译： 38-脱羧-338-羟甲基衍生物的布立康宁抗生素及其制备方法
公开(公告)号：US5869449A
公开(公告)日：1999-02-09
申请号：US872461
申请日：1997-06-10
申请人： Adriano Malabarba , Romeo Ciabatti
发明人： Adriano Malabarba , Romeo Ciabatti
IPC分类号： A61K38/00 , A61P31/04 , C07K1/113 , C07K7/06 , C07K9/00 , A61K38/12 , C07K11/02
CPC分类号： C07K9/008 , A61K38/00 , Y02P20/55 , Y10S930/19
摘要： The present invention is directed to novel 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antiobiotics and a process for preparing them which includes submitted the corresponding lower alkyl ester precursor to a reduction reaction in the presence of an alkali metal borohydride. The compounds of the invention show an improved antibacterial activity against some clinical isolates of Staphylococci somewhat resistant to teicoplanin.The teicoplanin derivatives of the present invention are represented by the following formula: ##STR1## wherein: X represents hydroxymethyl;R represents hydrogen or --N�(C.sub.9 -C.sub.12)aliphatic acyl!-.beta.-D-2-deoxy-2-aminoglucopyranosyl;R.sub.1 represents hydrogen or N-acetyl-.beta.-D-2-deoxy-2-aminoglucopyranosyl;R.sub.2 represents hydrogen of alpha-D-mannopyranosyl;R.sub.3 represents hydrogen or a protecting group of the amino function; and the acid addition salts thereof; with the proviso that R.sub.1 represents hydrogen only when R and R.sub.2 are simultaneously hydrogen.
摘要翻译：本发明涉及替考拉宁抗生素的新型38-脱羧基-3-羟甲基衍生物及其制备方法，其包括在碱金属硼氢化物存在下将相应的低级烷基酯前体进行还原反应。本发明的化合物显示出对某些对替考拉宁耐药的葡萄球菌的一些临床分离物具有改善的抗菌活性。本发明的替考拉宁衍生物由下式表示：其中：X代表羟甲基; R代表氢或-N [（C 9 -C 12）脂族酰基]-β-D-2-脱氧-2-氨基吡喃葡萄糖基; R1代表氢或N-乙酰基-β-D-2-脱氧-2-氨基吡喃葡萄糖基; R2表示α-D-吡喃甘露糖基的氢; R3表示氢或氨基官能团的保护基; 及其酸加成盐; 条件是仅当R和R 2同时为氢时，R 1表示氢。

30. 发明授权

US5674840A Synthetic aglucodalbaheptide antibiotics 失效
标题翻译：合成抗菌素类抗生素
公开(公告)号：US5674840A
公开(公告)日：1997-10-07
申请号：US532629
申请日：1995-12-26
申请人： Adriano Malabarba , Romeo Ciabatti
发明人： Adriano Malabarba , Romeo Ciabatti
IPC分类号： A61K38/00 , A61K38/08 , A61K38/14 , A61P31/04 , C07K1/06 , C07K7/06 , C07K9/00
CPC分类号： C07K7/06 , C07K9/008 , Y02P20/55
摘要： Synthetic aglucodalbaheptides of formula (I) wherein W and Z, each independently, represent the relative portions of the aglycon of an antibiotic of the dalbaheptide group. Y represents a carboxylic group or a functional derivative of said carboxylic group; R and R.sub.1, each independently, represent hydrogen or a protecting group of the amino function. R.sub.2 represents hydrogen; and their salts with acid and bases as well as their inner salts. A process for producing the aglucodabaheptides of formula (I) and their use as medicaments.
摘要翻译： PCT No.PCT / EP94 / 01154 Sec。 371日期1995年12月26日第 102（e）日期1995年12月26日PCT 1994年4月14日PCT PCT。公开号WO94 / 26780 PCT 日期1994年11月24日式（I）的合成氨基甜菜苷类化合物其中W和Z各自独立地代表达那贝肽组抗生素的糖苷配基的相对部分。 Y表示所述羧基的羧基或官能衍生物; R和R 1各自独立地表示氢或氨基官能团的保护基。 R2表示氢; 和它们与酸和碱的盐以及它们的内盐。制备式（I）的吡啶并庚啶的方法及其作为药物的用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式